Merck
MRK
#62
Rank
NZ$432.44 B
Marketcap
NZ$173.13
Share price
-1.16%
Change (1 day)
0.99%
Change (1 year)

Merck (MRK) - Total debt

Total debt on the balance sheet as of September 2025 : NZ$71.83 Billion

According to Merck's latest financial reports the company's total debt is NZ$71.83 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Merck - Total debt on balance sheet (from 1996 to 2025)

Total debt by year

Year Total debt Change
2024-12-31NZ$65.80 B18.71%
2023-12-31NZ$55.43 B14.67%
2022-12-31NZ$48.33 B-0.25%
2021-12-31NZ$48.46 B9.99%
2020-12-31NZ$44.05 B12.63%
2019-12-31NZ$39.11 B4.48%
2018-12-31NZ$37.44 B8.93%
2017-12-31NZ$34.37 B-4.16%
2016-12-31NZ$35.86 B-7.07%
2015-12-31NZ$38.59 B41.27%
2014-12-31NZ$27.31 B-10.42%
2013-12-31NZ$30.49 B21.96%
2012-12-31NZ$25.00 B11.41%
2011-12-31NZ$22.44 B-3.18%
2010-12-31NZ$23.17 B-3.66%
2009-12-31NZ$24.05 B123.73%
2008-12-31NZ$10.75 B43.52%
2007-12-31NZ$7.49 B-22.78%
2006-12-31NZ$9.70 B-18.1%
2005-12-31NZ$11.84 B23%
2004-12-31NZ$9.63 B-7.87%
2003-12-31NZ$10.45 B-36%
2002-12-31NZ$16.33 B-23.49%
2001-12-31NZ$21.34 B36.72%
2000-12-31NZ$15.61 B35.94%
1999-12-31NZ$11.48 B57.44%
1998-12-31NZ$7.29 B88.26%
1997-12-31NZ$3.87 B55.4%
1996-12-31NZ$2.49 B

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Pfizer
PFE
NZ$105.64 B 47.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$79.50 B 10.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$73.79 B 2.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$88.61 B 23.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$44.32 B-38.29%๐Ÿ‡ซ๐Ÿ‡ท France
GlaxoSmithKline
GSK
NZ$41.42 B-42.33%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
NZ$29.64 B-58.73%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Novartis
NVS
NZ$55.59 B-22.60%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Abbott Laboratories
ABT
NZ$22.46 B-68.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$94.77 B 31.94%๐Ÿ‡บ๐Ÿ‡ธ USA